Two Sigma Advisers LP Lowers Position in Fate Therapeutics, Inc. (NASDAQ:FATE)
Two Sigma Advisers LP lessened its position in Fate Therapeutics, Inc. (NASDAQ:FATE – Free Report) by 10.7% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 828,100 shares of the biopharmaceutical company’s stock after selling 99,140 shares during the quarter. Two Sigma […]
Two Sigma Advisers LP lessened its position in Fate Therapeutics, Inc. (NASDAQ:FATE – Free Report) by 10.7% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 828,100 shares of the biopharmaceutical company’s stock after selling 99,140 shares during the quarter. Two Sigma […]
